Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research Inc is a specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units, the Topical Products and Technology (TPT) Group and the Immunology Group.
Price: $5.84 | Change: $-0.06 | %Change: -1.02%
Volume: 27,660 | Day High/Low: 5.90/5.66 | 52 Week High/Low: 10.36/2.57
View modes: 
0 stars

RE:Q2 had some very good P2 sales numbers

Good numbers of about 7500 Rxs which is the second highest on record. At this time if the year......holidays for physicians , salesmen and patients offset by refill accruals..you can expect much...read more
0 stars

RE:Inflamax WF10 Study

Attached is the brocuhure which matches up to the WF10 study almost perfectly. http://www.sneezetoronto.com/wp-content/uploads/2015/05/GrassAndRagweedBrochure.pdf  rate and reply
0 stars

Exclusive Interview – Michael Dalsin Explains V.PHM

“The real beneficiaries are the Canadian investors. They invested between 10-40 cents, 80 cents, and a dollar. PHM has had a very nice share appreciation. Twenty-two months ago when we got into this business, I think it had about half-a-million in profits. It now has $30 million in profits. That’s a tremendous increase and share price is reflecting that and will most likely continue to do so.” ...read more
0 stars

Inflamax WF10 Study

It would appear that the Nuvo study with Inflamax is full, which is good news (of course this is assuming that the grass and ragweed study is the WF10 study).  http://www.sneezetoronto.com/grass-and...read more
0 stars

Q2 had some very good P2 sales numbers

* record quarter in revnue for NRI should be in the works baed on all public data. * on a go forward basis the revenue numbers should continue to improve and as previulsy stated I am more than happy...read more
0 stars

RE:New Presentation Out - 2% Scripts Going Back Up

Thanks for the update, Mr. Fox.  The slope of the upward line might be unknown, but the overall trend is still upward and should continue that way for some considerable time.  rate and reply
0 stars

New Presentation Out - 2% Scripts Going Back Up

Looks like about 7500 in latest presentation.  Not sure if the date is right (June 19th).  Wonder when the 2% trial in Europe will start.  rate and reply
0 stars

Globe & Mail - Report on Business

In the Friday ROB magazine for July / August in the Globe & Mail, the Top 1000 Canadian companies were ranked. Nuvo was listed as a Newcomer and ranked # 232. Further, it was ranked # 4 for Biggest by...read more
0 stars

RE:RE:Average Rx refill time

Thanks for that extra info. Concentration is 20 mg per ml so the most taken per day at two pumps twice daily would be about 4 weeks. If you aaplied every day but only once daily. The 112 ml bottle...read more
5 stars

RE:Average Rx refill time

About PENNSAID 2% Safety How to Apply PENNSAID 2% FAQs Frequently Asked Questions (FAQs) How much PENNSAID® (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%) can I use each day...read more
5 stars

Average Rx refill time

My best estimate...and it is a sloppy one..is 3 months. Application variability can be quite different amongst individuals.. P2 dispenser is twice as large as P1. From this, it looks like 1 Rx = 1...read more
0 stars

RE:If Peensaid 1 got these strong patient reviews......

This article came out a few days ago ....read the last paragraph to remove any fears of a failed trial in Germany... http://osteoarthritis.about.com/od/osteoarthritistreatments/a/pennsaid_topical...read more
0 stars

If Peensaid 1 got these strong patient reviews......

...you can imagine the exemplary reviews P2 will get... http://www.webmd.com/drugs/drugreview-153886-Pennsaid+Top.aspx?drugid=153886&drugname=Pennsaid+Top&pageIndex=1&sortby=3&conditionFilter=-500  rate and reply
0 stars

RE:US $10 million binding contracts

It is not a simple task. July product supply would have been forecasted for accrued data up to March 31/15. March was a strong growth month. August  from accrued data up to April 31. April was a slow...read more
0 stars

RE:US $10 million binding contracts

That would require about 8000 scripts per week. Would they have foreseen that in April? of course they can always negotiate. With both physicians and salesmen taking summer holidays, We may see a...read more
5 stars

US $10 million binding contracts

Expected at June end for July August and September imo  rate and reply
5 stars

RE:12 Month Rolling Supply Chain Management

ITS GOOD TO SEE A SIMPLE EXAMPLE OF HOW THE ROLLING SUPPLY FORECAST WORKS. ITS NOW QUITE UNDERSTANDABLE, BUT NOT WITHOUT DOING ADDITIONAL DIGGING.    AT THE END OF DECEMBER   Horizon HAD...read more
5 stars

RE:RE:RE:News Updates...P2 to start Trial in Early July +

Looks like as word got out today of the news release it began to see some buying urgency and many bids appeared as should be the case for the next while now that the trials are approved and imminent...read more
5 stars

RE:RE:News Updates...P2 to start Trial in Early July +

Great news to here that the test will focus on ankle sprains. Pennsaid was prescibed by my physician for bursitis and inflammation due to an industrial accident I suffered years back. Not only will it...read more
4 stars

RE:RE:News Updates...P2 to start Trial in Early July +

Actually I was under the impression the trials were to begin in Q2 which means that we are off to a later start. I am relieved nonetheless that Nuvo has regulatory approval to proceed. Shareholders...read more
0 stars

12 Month Rolling Supply Chain Management

Like most drug companies, Horizon uses a rolling 12 month product supply forecast. In the case of Nuvo's contract, such forecasts must be received at least 90 days prior to shipping. This rolling...read more